Keyphrases
Pulmonary Hypertension
100%
Rho Kinase
100%
TWIK2
100%
Knock-in Mouse Model
50%
Right Ventricular Systolic Pressure
40%
Littermate
20%
Thromboxane A2 (TXA2)
10%
Pulmonary Artery
10%
Vascular System
10%
Contractile Response
10%
Cross-sectional Area
10%
U46619
10%
Drinking Water
10%
Vessel Wall
10%
Potassium Channel
10%
Pulmonary Vasculature
10%
Pulmonary Vascular Remodeling
10%
Y-27632
10%
Pore Domain
10%
Rho Kinase Inhibitor Fasudil
10%
KCNK6
10%
Secondary Branch
10%
Rho Kinase Inhibitor
10%
Vessel Remodeling
10%
Medicine and Dentistry
Pulmonary Hypertension
100%
Rho Kinase
100%
Systolic Blood Pressure
80%
Nevus
40%
Rho Kinase Inhibitor
40%
Downregulation
20%
Thromboxane A2
20%
Vascular System
20%
Pulmonary Artery
20%
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
20%
Potassium Channel
20%
Pulmonary Vasculature
20%
Vascular Remodeling
20%
Fasudil
20%
Y-27632
20%
Pharmacology, Toxicology and Pharmaceutical Science
Knockout Mouse
100%
Pulmonary Hypertension
100%
Rho Kinase
100%
Mole (Insectivora)
40%
Rho Kinase Inhibitor
40%
Mouse
20%
Potassium Channel
20%
Thromboxane A2
20%
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
20%
Vascular Remodeling
20%
Fasudil
20%
4 (1 Aminoethyl) N (4 Pyridyl)cyclohexanecarboxamide
20%
Immunology and Microbiology
Knockout Mouse
100%
Systolic Blood Pressure
80%
Mole (Insectivora)
40%
Mouse
20%
Downregulation
20%
Vascularization
20%
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
20%
Pulmonary Artery
20%
Potassium Channels
20%
Thromboxane A2
20%